Zoryve (roflumilast) is a cream and foam that's approved for treating certain skin conditions in adults and children. The 0.15% cream is used to treat eczema and the 0.3% cream is used to treat plaque psoriasis. The 0.3% foam is approved for seborrheic dermatitis. Zoryve (roflumilast) is a phosphodiesterase 4 (PDE4) inhibitor. It's thought to lessen inflammation on the skin by lowering the activity of a protein in the body called PDE4. Zoryve (roflumilast) is applied to the affected area(s) on the skin once a day. Side effects can include pain where you apply the medication and headache.
Zoryve (roflumilast) is a phosphodiesterase 4 (PDE4) inhibitor. It blocks a protein in the body called PDE4. This protein plays a role in causing inflammation in your body.
By blocking PDE4, Zoryve (roflumilast) lowers the protein's ability to cause inflammation. This is thought to help relieve signs and symptoms of plaque psoriasis, eczema, and seborrheic dermatitis.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No, Zoryve (roflumilast) isn't a steroid. This medication belongs to a different class of medications called PDE4 inhibitors. Like steroids, Zoryve (roflumilast) helps lessen skin inflammation, but it works differently. Zoryve (roflumilast) also causes different side effects than topical steroids. Studies show that it's generally safe to use Zoryve (roflumilast) for long-term treatment. On the other hand, it's generally recommended to use topical steroids only for a few weeks at a time to avoid skin thinning and other side effects. Talk with your dermatologist to determine which medication is best for you.
In clinical studies, about 40% of people with plaque psoriasis had clear or almost clear skin after they used the 0.30% Zoryve (roflumilast) cream every day for 8 weeks. Ask your dermatologist for more information if you have any questions about Zoryve (roflumilast).
Yes, the FDA recently approved the 0.15% strength of the Zoryve (roflumilast) cream for eczema in people 6 years of age and older. This approval is based on findings from studies that showed that the medication works well to improve symptoms of eczema. About 30% of people with eczema had clear or almost clear skin after they used the 0.15% Zoryve (roflumilast) cream every day for 4 weeks.
In a clinical study, almost 80% of people with seborrheic dermatitis had clear or almost clear skin after they used the 0.3% Zoryve (roflumilast) foam every day for 8 weeks. Discuss with your dermatologist to learn more about Zoryve (roflumilast).
There's some evidence that Zoryve (roflumilast) is safe to use on the face. One study showed that using Zoryve (roflumilast) on the face didn't cause worrisome side effects that steroids sometimes cause, such as thinning of the skin. But in general, you should avoid getting Zoryve (roflumilast) in your eyes, nose, and mouth to prevent irritation. Ask your dermatologist if you have questions on where you should apply Zoryve (roflumilast).
The time it will take for Zoryve (roflumilast) to work is different for everyone. For plaque psoriasis and seborrheic dermatitis, you might start to notice improvement in your symptoms within the first 2 weeks after you start treatment. For eczema, some people who participated in clinical studies reported improvement in itch as early as a day after they started using Zoryve (roflumilast). Keep in mind that it can take a few months or longer for you to see the full effects of the medication. Talk to your dermatologist if you don't notice any symptom relief within the first few weeks of starting Zoryve (roflumilast).
No, Zoryve (roflumilast) isn't a biologic. A biologic is a medication that comes from a living source, such as proteins. Instead, Zoryve (roflumilast) is a chemical that's made in a laboratory.
Zoryve (roflumilast) and Vtama (tapinarof) both help treat plaque psoriasis. They both come as a cream that's applied once daily to the affected area(s). But Zoryve and Vtama work differently to treat plaque psoriasis. They're also approved for use in different age groups. Vtama is only approved for adults, whereas Zoryve can be used for people 6 years and older. Additionally, there are other strengths and formulations of Zoryve that are approved for other skin conditions (eczema and seborrheic dermatitis). Follow up with your dermatologist to learn more about comparing between Zoryve and Vtama.
Zoryve (roflumilast) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
The foam version of Zoryve (roflumilast) is flammable and it can catch on fire easily. Keep the foam can away from flames or lit cigarettes while you're applying Zoryve (roflumilast) and also right after you apply the medication onto your skin.
Apply a thin layer to the affected area(s) on the skin once daily and rub the medication in completely.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Zoryve (roflumilast) will not be safe for you to take.